Who We Are
Targeting at the worldwide Preventive Medicine market.
Committed to research, develop and market non-invasive monitoring technology with various physiological signals.
Acquired 64 patents from EU, Japan, USA, China and Taiwan.
Technology Application
High-Efficient Reflective Physiological Sensors
Medical Algorithms
for Physiological Parameters
Wearable Medical Devices
Total Solution for Specific Applications
History
Independent from Industrial Technology Research Institute (ITRI) and established.
Obtained ISO 13485 certification for medical device quality management system.
<table class="border_none"> <tbody> <tr> <td>●</td> <td>Obtained Good Manufacturing Practice (GMP) certification by Taiwan Ministry of Health and Welfare.</td> </tr> <tr> <td>●</td> <td>Obtained the medical device business permits license.</td> </tr> <tr> <td>●</td> <td>oCare Pro 100 acquired medical device certification by Taiwan Ministry of Health and Welfare.</td> </tr> </tbody> </table>
oCare Pro 100 acquired US FDA 510(K) clearance.
Obtained Registration Certificate of Foreign Medical Device Manufacturer.
Incorporation of the sleep analysis service into the hospital health screening system.
A Photoplethysmography-Based Continuous Automated Non-Invasive Sphygmomanometer was approved by the Research Ethics Committee of the Medical Center for clinical trials.
Continue
Intellectual Property Strategies for Innovative Technologies
tBPC has a number of invention patents, which can provide innovative and practical solutions in the field of non-invasive medical care, giving its products comprehensive market potential and competitive edge.
The patent portfolio is mainly in the following technical fields:
| ● | Non-invasive blood pressure measurement technology. |
| ● | Non-contact blood glucose measurement technology. |
| ● | Reflective Photoplethysmography signal detection technology. |
我們的團隊
文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案 文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案文案。
XXX
董事長
XXX
董事長
XXX
董事長
XXX
董事長
Our Team
